Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,102 public trials 1,782 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, not recruiting

A Study of the Safety and Preliminary Efficacy of NKG001 in Pediatric Patients With Type 1 or Type 2 Spinal Muscular Atrophy

NCT07617779

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations: Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

NCT05337553

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +6 more
Locations: Phoenix Children's Phoenix, Arizona, United States

UCSD & Rady Children's La Jolla, California, United States

Children's Hospital of Los Angeles Los Angeles, California, United States

UCSF Benioff Children's Hospital, Medical Center San Francisco, California, United States

View all 53 locations

View Trial Details

Active, not recruiting

A Study of Caregiver Connections Via Technology in Dementia

NCT05779839

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Behavior, +24 more
Locations: Mayo Clinic Rochester Rochester, Minnesota, United States

View Trial Details

Active, not recruiting

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

NCT03560960

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations: Indiana University Alzheimer Disease Center Indianapolis, Indiana, United States

BU Alzheimer Disease Center Boston, Massachusetts, United States

Memory Center VA Boston Healthcare Jamaica Plain, Massachusetts, United States

View Trial Details

Active, not recruiting

Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)

NCT05138263

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: SMG-SNU Boramae Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Active, not recruiting

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

NCT06602193

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Cedars-Sinai Department of Neurology Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

Parkinson's Disease and Movement Disorders Center Boca Raton, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 20 locations

View Trial Details

Active, not recruiting

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

NCT06958939

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: The Second Affiliated Hospital of Air Force Medical University Xi'an, Shaanxi, China

View Trial Details

Active, not recruiting

Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

NCT04055376

Conditions: Alzheimer Dementia, Alzheimer Disease, Brain Diseases, +9 more
Locations: Massachusetts Institute of Technology Cambridge, Massachusetts, United States

View Trial Details

Active, not recruiting

Myotonic Dystrophy - Vascular and Cognition

NCT04656210

Conditions: Carbohydrate Intolerance, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes, +22 more
Locations: Hopital Roger Salengro, CHU Lille Lille, France

View Trial Details

Active, not recruiting

A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)

NCT05067790

Conditions: Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

Stanford Neuroscience Health Center Palo Alto, California, United States

Rare Disease Research, LLC Atlanta, Georgia, United States

Boston Children's Hospital Boston, Massachusetts, United States

View all 22 locations

View Trial Details

Neurodegenerative Diseases

Neurodegenerative Diseases trial results

Related conditions